Novel (serotonin receptor partial agonist (5-HT1A))

  • Generalized Anxiety1
  • Major Depression with anxiety2
  • Sexual dysfunction on SSRI2
  • Bruxism2
  • Irritability in TBI2
  • Premenstrual dysphoria2
  • ADHD3

Dosing

Divide BID or TID, with usual dose 60-90 mg/d, start 5-7.5 mg BID

Management

Well-tolerated (Dizziness, nervousness, nausea, headache, jitteriness). Can cause mania. Metabolized through CYP3A4.

Not very effective in depression augmentation, but very well-tolerated.

EMR Text

Diagnosis1

StartText1

WarningText1

Diagnosis2

StartText2

WarningText2

Scroll to Top